CoChat

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Open access
Paz-Ares, Luis G., Juan-Vidal, Oscar, Mountzios, Giannis S., Felip, Enriqueta, Reinmuth, Niels, de Marinis, Filippo, Girard, Nicolas, Patel, Vipul M., Takahama, Takayuki, Owen, Scott P., Reznick, Douglas M., Badin, Firas B., Cicin, Irfan, Mekan, Sabeen, Patel, Riddhi, Zhang, Eric, Karumanchi, Divyadeep, Garassino, Marina Chiara, Ahern, Elizabeth, Chin, Venessa, Della-Fiorentina, Stephen, Jasas, Kevin, Karapetis, Christos, Long, Jeremy, Nott, Louise, O'Byrne, Kenneth, Underhill, Craig, Greil, Richard, Hochmair, Maximilian, Pircher, Andreas, Demey, Wim, Germonpré, Paul, Govaerts, Elke, Pieters, Thierry, Wener, Reinier, Azambuja, Alan, Borges, Giuliano, Castro, Gilberto, Castro, Suellen, Cruz, Felipe, Franke, Fábio, Silva, Eduardo, Cheema, Parneet, El-Maraghi, Robert, Kulkarni, Swati, Nassabein, Rami, Owen, Scott, Audigier Valette, Clarisse, Bennouna, Jaafar, Chouaid, Christos, Cortot, Alexis, Couraud, Sebastien, Debieuvre, Didier, Denis, Fabrice, Dumont, Patrick, Gervais, Radj, Girard, Nicolas, Giroux Leprieur, Etienne, Guisier, Florian, Hiret, Sandrine, Janicot, Henri, Lamour, Corinne, Madelaine, Jeannick, Marcq, Marie, Pluquet, Emilie, Louis Pujol, Jean, Ravoire, Magali, Sabatini, Marielle, Vergnenegre, Alain, Bohnet, Sabine, Faehling, Martin, Janning, Melanie, Laack, Eckart, Reinmuth, Niels, Rittmeyer, Achim, Wesseler, Claas, Baka, Sofia, Fountzilas, George, Katsaounis, Panagiotis, Kotsakis, Athanasios, Mountzios, Ioannis, Syrigos, Konstantinos, Dudnik, Julia, Carmel, Fink, Merimsky, Ofer, Nechushtan, Hovav, Sobolev, Julia, Agustoni, Franceso, Cecilia Bettini, Anna, Brighenti, Matteo, Cerea, Giulio, De Marinis, Filippo, Grisanti, Salvatore, Grossi, Francesco, Luciani, Andrea, Maiello, Evaristo, Soto Parra, Hector, Tassone, Pierfrancesco, Tonini, Giuseppe, Agemi, Yoko, Azuma, Koichi, Baba, Tomohisa, Fujita, Yuka, Ichihara, Eiki, Kasai, Takashi, Kato, Terufumi, Kobayashi, Haruki, Kuyama, Shoichi, Nishino, Kazumi, Oki, Masahide, Okishio, Kyoichi, Sakamoto, Tomohiro, Sato, Yuki, Shinno, Yuki, Takahama, Takayuki, Takayama, Koichi, Watanabe, Yasutaka, Yanagitani, Noriko, Zenke, Yoshitaka, Motola Kuba, Daniel, Daniel Pineda Razo, Tomas, Cornelissen, Robin, Hendriks, Lizza, Kloover, Jeroen, Maas, Klaar, van der Leest, Cor, Bodnar, Lubomir, Karaszewska, Boguslawa, Mruk, Andrzej, Alves, Paula, Araujo, Antonio, Domingues, Isabel, da Conceicao Fernandes Rodrigues, Ana, Gil, Nuno, Magalhaes, Helena, Parente, Barbara, Correa, Marcia, Velez-Cortes, Hector, Aguilar Hernandez, Andres, Alonso Calderon, Ruben, Barrera, Joaquim, Baz, David, Calles, Antonio, Campelo, Maria, Carpeno, Francisco, Costa, Enric, Dols, Manuel, Domine Gomez, Manuel, Fernandez de Sanmamed, Miguel, Font, Enriqueta, Fuentes, Jose, Pilar Garrido Lopez, Maria, Juan Vidal, Oscar, Larriba, Jose, Martinez, Laia, Palmero Sanchez, Ramon, Ros Martinez, Silverio, Zugazagoitia Fraile, Jon, Bilici, Ahmet, Cicin, Irfan, Demirci, Umut, Eralp, Yesim, Gumus, Mahmut, Yazici, Ozan, Baijal, Shobhit, Clarke, Katy, Lim, Farah, Muthukumar, Dakshinamoorthy, Steele, Nicola, Summers, Yvonne, Abdelaziz, Ahmed, Avery, Eric, Badin, Firas, Connor, Charles, Daniel, Davey, Faridi, Amir, Fields-Meehan, January, Garassino, Marina, Gersten, Todd, Haggstrom, Daniel, Hakimian, David, Houck, William, Illum, Henrik, Keresztes, Roger, Kurkul, Charles, Kuzma, Charles, Lerner, Rachel, Liu, Steven, Menon, Smitha, Owera, Rami, Patel, Vipul, Percent, Ivor, Piper, Andrew, Prakash, Sucharu, Reznick, Douglas, Rios-Perez, Jorge, Sun, Jun, Tibayan, Restituto, Traynor, Anne, Walsh, William, Wender, Donald · 2024 · Journal of Clinical Oncology
Cited by 137

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

PURPOSE: The open-label, phase III EVOKE-01 study evaluated sacituzumab govitecan (SG) versus standard-of-care docetaxel in metastatic non–small cell lung cancer (mNSCLC) with progression on/after platinum-based chemotherapy, anti–PD-(L)1, and targeted treatment for actionable genomic alterations (AGAs). Primary analysis is reported. METHODS: Patients were randomly assigned 1:1 (stratified by histology, best response to last anti–PD-(L)1–containing regimen, and AGA treatment received or not) to SG (one 10 mg/kg intravenous infusion on days 1 and 8) or docetaxel (one 75 mg/m 2 intravenous infusion on day 1) in 21-day cycles. Primary end point was overall survival (OS). Key secondary end points were investigator-assessed progression-free survival (PFS), objective response rate, patient-reported symptom assessment, and safety. RESULTS: In the intention-to-treat population (SG, n = 299; docetaxel, n = 304), 55.4% had one previous line of therapy. Median follow-up was 12.7 months (range, 6.0-24.0). The primary end point was not met. There was a numerical OS improvement for SG versus docetaxel (median, 11.1 v 9.8 months; hazard ratio [HR], 0.84 [95% CI, 0.68 to 1.04]; one-sided P = .0534), consistent across squamous and nonsquamous histologies. Median PFS was 4.1 versus 3.9 months (HR, 0.92 [95% CI, 0.77 to 1.11]). An OS benefit was observed for SG (n = 192) versus docetaxel (n = 191) in mNSCLC nonresponsive to last anti–PD-(L)1–containing regimen (3.5-month median OS increase; HR, 0.75 [95% CI, 0.58 to 0.97]); this was consistent across histologies. Among patients receiving SG and docetaxel, 6.8% and 14.2% discontinued because of treatment-related adverse events (TRAEs), respectively; 1.4% and 1.0%, respectively, had TRAEs leading to death. CONCLUSION: Although statistical significance was not met, OS numerically improved with SG versus docetaxel, which was consistent across histologies. Clinically meaningful improvement in OS was noted in mNSCLC nonresponsive to last anti–PD-(L)1–containing regimen. SG was better tolerated than docetaxel and consistent with its known safety profile, with no new safety signals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.24.00733

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Paz-Ares, L. G., Juan-Vidal, O., Mountzios, G. S., Felip, E., Reinmuth, N., de Marinis, F., Girard, N., Patel, V. M., Takahama, T., Owen, S. P., Reznick, D. M., Badin, F. B., Cicin, I., Mekan, S., Patel, R., Zhang, E., Karumanchi, D., Garassino, M. C., Ahern, E., Chin, V., Della-Fiorentina, S., Jasas, K., Karapetis, C., Long, J., Nott, L., O'Byrne, K., Underhill, C., Greil, R., Hochmair, M., Pircher, A., Demey, W., Germonpré, P., Govaerts, E., Pieters, T., Wener, R., Azambuja, A., Borges, G., Castro, G., Castro, S., Cruz, F., Franke, F., Silva, E., Cheema, P., El-Maraghi, R., Kulkarni, S., Nassabein, R., Owen, S., Audigier Valette, C., Bennouna, J., Chouaid, C., Cortot, A., Couraud, S., Debieuvre, D., Denis, F., Dumont, P., Gervais, R., Girard, N., Giroux Leprieur, E., Guisier, F., Hiret, S., Janicot, H., Lamour, C., Madelaine, J., Marcq, M., Pluquet, E., Louis Pujol, J., Ravoire, M., Sabatini, M., Vergnenegre, A., Bohnet, S., Faehling, M., Janning, M., Laack, E., Reinmuth, N., Rittmeyer, A., Wesseler, C., Baka, S., Fountzilas, G., Katsaounis, P., Kotsakis, A., Mountzios, I., Syrigos, K., Dudnik, J., Carmel, F., Merimsky, O., Nechushtan, H., Sobolev, J., Agustoni, F., Cecilia Bettini, A., Brighenti, M., Cerea, G., De Marinis, F., Grisanti, S., Grossi, F., Luciani, A., Maiello, E., Soto Parra, H., Tassone, P., Tonini, G., Agemi, Y., Azuma, K., Baba, T., Fujita, Y., Ichihara, E., Kasai, T., Kato, T., Kobayashi, H., Kuyama, S., Nishino, K., Oki, M., Okishio, K., Sakamoto, T., Sato, Y., Shinno, Y., Takahama, T., Takayama, K., Watanabe, Y., Yanagitani, N., Zenke, Y., Motola Kuba, D., Daniel Pineda Razo, T., Cornelissen, R., Hendriks, L., Kloover, J., Maas, K., van der Leest, C., Bodnar, L., Karaszewska, B., Mruk, A., Alves, P., Araujo, A., Domingues, I., da Conceicao Fernandes Rodrigues, A., Gil, N., Magalhaes, H., Parente, B., Correa, M., Velez-Cortes, H., Aguilar Hernandez, A., Alonso Calderon, R., Barrera, J., Baz, D., Calles, A., Campelo, M., Carpeno, F., Costa, E., Dols, M., Domine Gomez, M., Fernandez de Sanmamed, M., Font, E., Fuentes, J., Pilar Garrido Lopez, M., Juan Vidal, O., Larriba, J., Martinez, L., Palmero Sanchez, R., Ros Martinez, S., Zugazagoitia Fraile, J., Bilici, A., Cicin, I., Demirci, U., Eralp, Y., Gumus, M., Yazici, O., Baijal, S., Clarke, K., Lim, F., Muthukumar, D., Steele, N., Summers, Y., Abdelaziz, A., Avery, E., Badin, F., Connor, C., Daniel, D., Faridi, A., Fields-Meehan, J., Garassino, M., Gersten, T., Haggstrom, D., Hakimian, D., Houck, W., Illum, H., Keresztes, R., Kurkul, C., Kuzma, C., Lerner, R., Liu, S., Menon, S., Owera, R., Patel, V., Percent, I., Piper, A., Prakash, S., Reznick, D., Rios-Perez, J., Sun, J., Tibayan, R., Traynor, A., Walsh, W., & Wender, D.
Venue
Journal of Clinical Oncology
Published
2024-08-20
Volume
42
Issue
24
Pages
2860-2872
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W4399218268
Cited by
137
References
4
FWCI
34.96
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.